Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT

Document Type

Article

Abstract

Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant disease characterized by the development of vascular malformations (VMs) in organs such as the brain and lungs, as well as telangiectases on mucosal surfaces. Prophylactic treatment of organ VMs may prevent potential complications, such as hemorrhage. However, brain VM treatment-surgical resection, embolization, and/or radiosurgery-is not recommended for all patients due to the associated risks. Given the scarcity of data regarding HHT-related brain VM presentation and treatment trends in pediatric patients, we aim to describe the clinical presentations and the patterns of treatment of HHT-related brain VMs in a pediatric cohort, and compare pediatric trends to those of adults. Demographic and clinical data were analyzed in 114 pediatric patients with HHT-related brain VMs and compared with a cohort of 253 adult patients enrolled in the multicenter Brain Vascular Malformation Consortium HHT Project. Our data demonstrated that a higher proportion of pediatric patients with HHT-related brain VMs were symptomatic at presentation ( = 0.004). Moreover, a higher proportion of pediatric patients presented with intracranial hemorrhage ( < 0.001) and seizure ( = 0.002) compared to adult patients. Surgical resection was the most common brain VM treatment modality in both children and adults. We conclude that pediatric patients may be more likely to present with symptoms and complications from brain VMs, supporting the case for screening for brain VMs in children with HHT.

Publication Date

4-4-2023

Publication Title

Journal of clinical medicine

ISSN

2077-0383

Volume

12

Issue

7

PubMed ID

37048789

Digital Object Identifier (DOI)

10.3390/jcm12072704

Link to Full Text

Share

COinS